ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 142 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132,141 | -71.9% | 11,830 | -46.2% | 0.00% | -100.0% |
| Q2 2023 | $470,458 | -45.4% | 21,984 | +3.2% | 0.00% | -66.7% |
| Q1 2023 | $861,696 | -1.2% | 21,308 | +13.6% | 0.00% | 0.0% |
| Q4 2022 | $872,483 | -15.8% | 18,755 | -6.1% | 0.00% | 0.0% |
| Q3 2022 | $1,036,000 | +10.1% | 19,967 | +0.3% | 0.00% | +50.0% |
| Q2 2022 | $941,000 | -49.0% | 19,904 | -23.2% | 0.00% | -50.0% |
| Q1 2022 | $1,844,000 | -17.5% | 25,900 | -13.4% | 0.00% | 0.0% |
| Q4 2021 | $2,236,000 | +52.0% | 29,900 | +15.4% | 0.00% | +33.3% |
| Q3 2021 | $1,471,000 | +29.0% | 25,900 | 0.0% | 0.00% | +50.0% |
| Q2 2021 | $1,140,000 | -10.7% | 25,900 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $1,277,000 | +11.5% | 25,900 | -4.8% | 0.00% | 0.0% |
| Q4 2020 | $1,145,000 | -18.3% | 27,200 | -11.1% | 0.00% | 0.0% |
| Q3 2020 | $1,401,000 | -5.7% | 30,600 | +3.4% | 0.00% | -25.0% |
| Q2 2020 | $1,486,000 | -1.7% | 29,600 | +0.7% | 0.00% | -20.0% |
| Q1 2020 | $1,512,000 | -4.4% | 29,400 | +14.8% | 0.01% | +25.0% |
| Q4 2019 | $1,582,000 | +2.9% | 25,600 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $1,538,000 | -25.3% | 25,600 | +4.9% | 0.00% | -33.3% |
| Q2 2019 | $2,059,000 | -4.2% | 24,400 | +8.4% | 0.01% | 0.0% |
| Q1 2019 | $2,149,000 | +75.4% | 22,500 | +30.1% | 0.01% | +50.0% |
| Q4 2018 | $1,225,000 | -16.2% | 17,300 | +1.2% | 0.00% | 0.0% |
| Q3 2018 | $1,461,000 | -26.3% | 17,100 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $1,982,000 | -16.8% | 17,100 | -41.9% | 0.01% | -14.3% |
| Q1 2018 | $2,383,000 | +269.5% | 29,449 | +167.7% | 0.01% | +250.0% |
| Q4 2017 | $645,000 | +25.2% | 11,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $515,000 | +30.1% | 11,000 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $396,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |